8ZN-26215-38525
4 vaccinations
5 coded responses
35 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 801 / CO
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-08-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — day 28, dose 3MedDRA: Arthralgia, Fatigue, Headache, Myalgia, Nausea, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Terrible reaction after third dose- fever to 103, myalgia, arthralgia, HA, nausea, fatigue. Lasted for approximately 50 hrs after injectionMedDRA releases: 2024-11 · check-in free text available
- 2021-10-02
- 2021-10-09
- 2021-11-27
-
2022-08-30
Survey response — 12 months, dose 3MedDRA: Multiple pregnancy, Pre-eclampsia, Premature labour — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Triplet pregnancy- preterm labor, preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-08-31
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-13
Dose 4 — Moderna
-
2022-09-14
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-12-15
-
2023-03-14
Survey response — 6 months, dose 4MedDRA: Hypertension, Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-08-28 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Moderna | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymphadenopathy
Systemic reaction (other): Axillary lymphadenopathy
Release 9 — day 28, dose 3
Symptoms: Terrible reaction after third dose- fever to 103, myalgia, arthralgia, HA, nausea, fatigue. Lasted for approximately 50 hrs after injection
Release 12 — 12 months, dose 3
Symptoms: Triplet pregnancy- preterm labor, preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Multiple pregnancy | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Premature labour | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release